Institutional investors purchased a net $312.8 thousand shares of GHDX during the quarter ended December 2017 and now own 90.41% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAKER BROS. ADVISORS LP Bought 370.9 Thousand shares of Genomic Health Inc
ACADIAN ASSET MANAGEMENT LLC Bought 30.2 Thousand shares of Genomic Health Inc
AURORA INVESTMENT COUNSEL Bought 1.1 Thousand shares of Genomic Health Inc